EMA to Hold its Second Public Meeting on COVID-19 Vaccines
The agency is organizing a second public meeting on January 8, 2021 to discuss the assessment, approval, and roll-out of new COVID-19 vaccines.
The European Medicines Agency (EMA) is organizing a second public meeting regarding the assessment, approval, and roll-out of new COVID-19 vaccines. At the meeting, EMA will discuss plans to ensure the safety of COVID-19 vaccines and the roles that the European Commission and the national public health authorities will play in the roll-out of the vaccines, according to a press release dated Dec. 22, 2020.
The meeting will be held online on January 8 and will be attended by EMA executive director Emer Cooke and members of EMA’s human medicines and safety committees, among others. An online form is being made available for those who wish to submit questions to panelists at the meeting. The agency has requested that these questions be submitted by Dec. 31, 2020.
Source: EMA
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.
